Rani Therapeutics Holdings, Inc.
RANI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001856725
In the last 90 days, Rani Therapeutics Holdings, Inc. insiders filed 2 open-market purchases and 2 sales; 68 institutions reported holding it in 13F filings for Q2 2026, worth $34.7M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Rani Therapeutics Holdings, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 22 | 24 | +2 |
| Shares | 1.24M | 2.56M | +1.32M (+106.0%) |
| Value | $20.3M | $34.5M | +$14.2M (+70.1%) |
New holders (6)
Institutions that held Rani Therapeutics Holdings, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Alphabet Inc. | 714,471 | $9.64M | 0.31% |
| United Services Automobile Association | 481,300 | $6.50M | 0.12% |
| Lasry Marc | 62,828 | $848.0K | 0.42% |
| Millennium Management LLC | 32,525 | $439.0K | 0.00% |
| Goldman Sachs Group Inc | 26,820 | $362.0K | 0.00% |
| Royal Bank of Canada | 27 | $0 | 0.00% |
Sold out (4)
Institutions that held Rani Therapeutics Holdings, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Squarepoint Ops LLC | 50,000 | $818.0K |
| Caas Capital Management LP | 13,934 | $228.0K |
| Canton Hathaway, LLC | 5,000 | $82.0K |
| Signaturefd, LLC | 65 | $1.00K |